Workflow
Shanghai C&D INNOSTIC Medical Technology Group(301584)
icon
Search documents
9月22-28日A股IPO观察:摩尔线程科创板过会,4家企业获注册批文
Sou Hu Cai Jing· 2025-09-29 08:50
IPO Pipeline Overview - As of September 28, there are 279 companies in the IPO pipeline, with 20 on the Shanghai Main Board, 37 on the Sci-Tech Innovation Board, 23 on the Shenzhen Main Board, 28 on the Growth Enterprise Market, and 168 on the Beijing Stock Exchange [2] - The total number of companies in various stages includes 11 accepted, 238 under inquiry, 9 approved, 4 suspended, and 14 submitted for registration [3] Newly Listed Companies - From September 22 to September 28, five companies were newly listed: - Shanghai YouSheng Aluminum Co., Ltd. on September 23, stock code 603418 [4] - Shanghai Jianfa Zhixin Medical Technology Group Co., Ltd. on September 25, stock code 301584 [6] - Suzhou Huichuan United Power System Co., Ltd. on September 25, stock code 301656 [7] - Zhejiang Jinhua New Materials Co., Ltd. on September 25, stock code 920015 [8] - Beijing HaoChuang RuiTong Electric Equipment Co., Ltd. on September 26, stock code 301668 [9] Company Performance on Listing Day - Shanghai YouSheng Aluminum closed at 79.50 CNY per share, with a 71.48% increase and a trading volume of 2.412 billion CNY [5] - Shanghai Jianfa Zhixin closed at 36.56 CNY per share, with a 418.58% increase and a trading volume of 1.477 billion CNY [6] - Suzhou Huichuan United Power closed at 30.90 CNY per share, with a 147.60% increase and a trading volume of 4.118 billion CNY [7] - Zhejiang Jinhua New Materials closed at 42.29 CNY per share, with a 133.00% increase and a trading volume of 1.132 billion CNY [8] - Beijing HaoChuang RuiTong closed at 60.06 CNY per share, with a 190.76% increase and a trading volume of 1.188 billion CNY [9] New Counseling Record Companies - Ten companies were newly recorded for counseling from September 22 to September 28, including: - Chongqing Radio and Television Digital Media Co., Ltd. [10] - Chengxing Aviation Co., Ltd. [11] - Shanghai Qixiang New Materials Technology Co., Ltd. [12] - Anhui Dachang Technology Co., Ltd. [13] - Shandong Ocean Shipping Group Co., Ltd. [14] - Sichuan Daohong New Materials Co., Ltd. [15] - Jiangxi Changxing Aviation Equipment Co., Ltd. [16] - Shanghai Chaoqun Testing Technology Co., Ltd. [17] - Shanghai Wenyin Electric Co., Ltd. [18] - Aike Medical Devices (Beijing) Co., Ltd. [19] Companies Approved for Registration - Four companies received registration approval from September 22 to September 28: - Hai'an Rubber Group Co., Ltd. on September 25 [20] - China Uranium Corporation on September 26 [21] - Jiangsu Jingchuang Electric Co., Ltd. on September 26 [22] - Harbin Itama Dapeng Industrial Co., Ltd. on September 26 [23]
39只A股筹码大换手(9月29日)
Market Overview - As of September 29, the Shanghai Composite Index closed at 3862.53 points, up 34.43 points, with a gain of 0.90% [1] - The Shenzhen Component Index closed at 13479.43 points, up 270.43 points, with a gain of 2.05% [1] - The ChiNext Index closed at 3238.01 points, up 86.48 points, with a gain of 2.74% [1] Stock Performance - A total of 39 A-shares had a turnover rate exceeding 20% on this day, indicating significant trading activity [1] - Notable stocks with high turnover rates include: - C Haocreat (301668) with a turnover rate of 62.30% and a closing price of 58.78 yuan, down 3.73% [1] - C Jianfa Zhi (301584) with a turnover rate of 61.32% and a closing price of 34.12 yuan, up 13.73% [1] - Jin Hua New Materials (920015) with a turnover rate of 53.44% and a closing price of 53.00 yuan, down 3.58% [1] - Other stocks with notable turnover rates include: - C United Motion (301656) at 41.80% and a closing price of 32.77 yuan, up 3.87% [1] - Zhongdian Xinlong (002298) at 39.78% and a closing price of 11.99 yuan, down 6.77% [1] - Chuling Information (300250) at 35.58% and a closing price of 26.40 yuan, up 20.00% [1] Additional Notable Stocks - Huijin Co., Ltd. (300368) had a turnover rate of 33.76% and closed at 19.08 yuan, up 20.00% [1] - Li Hexing (301013) closed at 30.75 yuan with a turnover rate of 33.58%, up 5.56% [1] - Other stocks with significant trading activity include: - Weili Transmission (300904) at 31.67% and a closing price of 85.80 yuan, up 8.24% [1] - Huarun Technology (002453) at 31.36% and a closing price of 7.90 yuan, down 10.02% [1]
建发致新:公司在业务规划中探索终端新兴产品或者业务模式的可能性
Zheng Quan Ri Bao Wang· 2025-09-29 08:13
证券日报网讯建发致新9月29日在互动平台回答投资者提问时表示,在人口老龄化背景下,公司会听取 投资者建议,在业务规划中探索终端新兴产品或者业务模式的可能性。 ...
次新股异动 建发致新涨超15%
Xin Lang Cai Jing· 2025-09-29 06:09
Group 1 - Newly listed stocks experienced significant movements, with C Jianfa rising over 15% [1] - Other companies such as C United Power, C Haocreat, Guangdong Jianke, and C Yousheng also saw substantial increases [1]
小长假前波动略有加剧,短周期新股板块或延续震荡分化走势
Huajin Securities· 2025-09-28 10:46
Group 1 - The new stock market is experiencing a slight increase in volatility before the holiday, with short-term new stock sectors likely to continue a trend of oscillation and differentiation [1][11] - The average increase of new stocks listed since 2024 is approximately -0.8%, with about 28.5% of new stocks showing positive returns [1][27] - The upcoming National Day holiday is expected to heighten external uncertainty, impacting market sentiment and pricing indicators, which are currently at relatively high historical levels [2][11] Group 2 - Recent new stock issuance has seen an average price-to-earnings ratio of 14.2X, with a low average subscription success rate of 0.0216% [4][21] - The first-day average increase for newly listed stocks was about 207%, indicating stable trading sentiment, while the average increase for the first week was 178.3% [24][25] - The sectors showing the most significant gains include semiconductor equipment and AI application themes, while those with the largest declines are primarily stocks that had previously shown high activity but have recently lost momentum [27][29] Group 3 - Upcoming new stocks include companies like Ruili Kemi and Yunhan Xincheng, with average issuance price-to-earnings ratios for new stocks expected to be around 19.9X [3][31] - The report suggests focusing on sectors with relative value, particularly in new energy, consumption, and non-ferrous metals, as well as long-term themes like robotics and innovative pharmaceuticals [2][11] - The report emphasizes the importance of flexibility in investment strategies due to the anticipated market volatility surrounding the holiday [38]
建发致新:公司现有的研发经费主要投资于医疗器械流通数字化方向
Zheng Quan Ri Bao Wang· 2025-09-26 13:17
Group 1 - The company is currently focused on distribution activities for surgical robot products and is not engaged in research and manufacturing [1] - There are no recorded research and development expenses for medical brain-machine interfaces and humanoid robots [1] - The existing research funding is primarily invested in the digitalization of medical device distribution, including business systems, data platforms, and SPD information systems [1]
51只A股筹码大换手(9月26日)
Market Overview - As of September 26, the Shanghai Composite Index closed at 3828.11 points, down 25.20 points, a decline of 0.65% [1] - The Shenzhen Component Index closed at 13209.00 points, down 236.90 points, a decline of 1.76% [1] - The ChiNext Index closed at 3151.53 points, down 84.23 points, a decline of 2.60% [1] Stock Performance - A total of 51 A-shares had a turnover rate exceeding 20% on this day, indicating significant trading activity [1] - Notable stocks with high turnover rates included: - C Haocreat (301668) with a turnover rate of 81.60% and a price increase of 190.76% [1] - Jin Hua New Materials (920015) with a turnover rate of 74.80% and a price increase of 29.98% [1] - C Jianfa Zhi (301584) with a turnover rate of 62.67% and a price decrease of 17.94% [1] - Zhongdian Xinlong (002298) with a turnover rate of 52.78% and a price decrease of 6.74% [1] Additional Notable Stocks - Other stocks with significant turnover rates included: - C United Motion (301656) at 44.55% with a price increase of 2.10% [1] - B wavelength Optoelectronics (301421) at 35.92% with a price decrease of 7.32% [1] - Tianfu Long (603406) at 34.73% with a price increase of 3.24% [1] - Northern Long Dragon (301357) at 34.01% with a price increase of 3.11% [1] - Silicon Power (301629) at 32.73% with a price decrease of 6.22% [1]
建发致新:公司现有的研发经费主要投资医疗器械流通数字化方向,包括业务系统和SPD信息系统等方面
Mei Ri Jing Ji Xin Wen· 2025-09-26 09:25
Group 1 - The company is a key unit in the central and state-owned enterprise reform, focusing on medical surgical robots [2] - Currently, the company mainly engages in distribution activities for surgical robot products and does not conduct research and development or manufacturing [2] - There are no recorded research and development expenses for medical brain-machine interfaces and humanoid robots [2] Group 2 - The existing research and development funds are primarily invested in the digitalization of medical device distribution, including business systems, data platforms, and SPD information systems [2]
建发致新成功登陆深交所!
Quan Jing Wang· 2025-09-26 09:02
Group 1 - Shanghai C&D INNOSTIC Medical Technology Group Co., Ltd. successfully held its IPO ceremony on September 25 [2] - The company, founded in 2010 and headquartered in Shanghai, is a national medical device distributor and part of the C&D Group [3] - The company engages in direct sales and distribution of medical devices and provides centralized operation services for medical consumables to hospitals, maintaining long-term partnerships with over 100 well-known domestic and international high-value medical device manufacturers [3] Group 2 - Chairman Yu Feng emphasized that the company will leverage its listing as an opportunity to utilize capital market resources, focusing on industry pain points and enhancing hospital scenarios [9] - The company aims to embrace the intelligent era and actively serve the public and society, with a commitment to delivering better operational performance to shareholders and contributing to society [9]
建发致新:目前没有医疗脑机接口和人形机器人这方面研发费用投入的记录
Ge Long Hui· 2025-09-26 09:01
Group 1 - The company is currently focused on distribution activities for surgical robot products and does not engage in research and manufacturing [1] - There are no recorded research and development expenses related to medical brain-machine interfaces and humanoid robots [1] - The existing research funding is primarily invested in the digitalization of medical device distribution, including business systems, data platforms, and SPD information systems [1]